首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1533601

蛋白質體學市場規模、佔有率和成長分析：按儀器技術、按試劑、按應用、按地區 - 產業預測，2024-2031

Proteomics Market Size, Share, Growth Analysis, By Instrumentation Technology, By Reagent, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年08月04日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球蛋白質體學市場規模將為252億美元，從2023年的293.5億美元成長到2031年的1001.7億美元，在預測期間（2024-2031年）預計複合年成長率為16.55%。

根據SkyQuest分析，全球將有1930萬新癌症病例和1000萬癌症相關死亡。心血管疾病（CVD）仍然是全世界死亡的主要原因之一。根據世界衛生組織 (WHO) 的報告，每年有 4,100 萬人死於這些疾病。因此，危及生命的疾病的盛行率不斷增加，增加了對個人化治療的需求，並對產業產生了積極影響。癌症、心血管疾病、呼吸系統疾病和慢性腎臟病（CKD）等慢性病盛行率的增加預計也將推動市場成長。研發投資的增加也是關鍵促進因素。美國國立衛生研究院 (NIH) 開展了 370 個生物醫學研究項目，以支持旨在闡明基本疾病過程的生命科學研究，包括識別生物標記和致病基因/蛋白質，我們已撥款 10 億美元。此外，諾和諾德基金會還津貼高達 150 萬美元，在哥本哈根大學建立質譜設施，這是蛋白質研究的重大進展。隨著活動從大流行造成的破壞中恢復，全球蛋白質體市場預計將獲得動力。

市場概況
光譜學
- 質譜分析
- 核磁共振波譜
- 圓二色光譜法
層析法
- HPLC
- 離子層析法
- 親和層析法
- 超臨界流體層析
電泳
- 凝膠電泳
- 毛細管電泳
蛋白質微陣列
- 生物晶片
- 實驗室晶片
- 蛋白質晶片
- 微陣列設備
- 綜合系統
- 微陣列掃描儀
- 阿萊亞
X光結晶結構分析
表面等離子體共振
蛋白質部分
其他技術

蛋白質體學市場：按試劑分類

市場概況
免疫檢測試劑
光譜試劑
層析法
蛋白質微陣列試劑
X光結晶結構分析試劑
電泳試劑
蛋白質分級分離試劑
其他試劑

蛋白質體學市場：依服務/軟體分類

市場概況
核心蛋白質體學服務
- 蛋白質鑑定服務
- 蛋白質表徵服務
- 定量蛋白質體學服務
- 蛋白質精製服務
- 蛋白質分離服務
- 蛋白質序列分析服務
- 客自訂化驗服務
生物資訊軟體和服務
- 生物資訊服務
- 生物資訊學工具
- 生物資訊資料庫
光子網路
其他技術

蛋白質體學市場：依應用分類

市場概況
臨床診斷
- 癌症
- 感染疾病
- 糖尿病
- 神經系統疾病
- 自體免疫疾病
- 心血管疾病
- 其他臨床診斷應用
藥物發現/開發
- 目標發現
- 線索識別
- 臨床前研究
其他應用

蛋白質體學市場：依最終用戶分類

市場概況
醫院
臨床實驗室
製藥和生物技術公司
學術實驗室
其他最終用戶

蛋白質體學市場規模：按地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific Inc.（US）
Bio-Rad Laboratories, Inc.（US）
Merck KGaA（Germany）
Agilent Technologies, Inc.（US）
Bruker Corporation（US）
Danaher Corporation（US）
GE Healthcare（US）
PerkinElmer Inc.（US）
Waters Corporation（US）
Illumina, Inc.（US）
Eurofins Scientific（Luxembourg）
QIAGEN Bioinformatics（Netherlands）
Creative Proteomics（US）
Promega Corporation（US）
Sengenics（Singapore）
Biomax Informatics AG（Germany）
MS Bioworks LLC（US）
WuXi NextCODE（China）
Fios Genomics Ltd.（UK）
Biognosys AG（Switzerland）
Bioproximity（Switzerland）
MRM Proteomics Inc.（Canada）

簡介目錄

Product Code: SQMIG35G2281

Global Proteomics Market size was valued at USD 25.2 billion in 2022 and is poised to grow from USD 29.35 billion in 2023 to USD 100.17 billion by 2031, growing at a CAGR of 16.55% in the forecast period (2024-2031).

According to SkyQuest's analysis, there will be 19.3 million new cancer cases worldwide and 10 million cancer-related deaths. Cardiovascular diseases (CVDs) remain one of the leading causes of death globally. The World Health Organization (WHO) reports that target diseases kill 41 million people annually. Consequently, the rising prevalence of life-threatening diseases is driving the demand for personalized therapies, positively impacting the industry. The growing prevalence of chronic diseases such as cancer, CVDs, respiratory diseases, and chronic kidney disease (CKD) is also expected to fuel market growth. Increased investments in proteomics research and development are another key growth driver. The National Institutes of Health (NIH) in the United States allocated $37 billion for biomedical research, aiming to support life sciences research that seeks to understand fundamental disease processes, such as identifying biomarkers and the genes/proteins responsible for diseases. Additionally, the Novo Nordisk Foundation awarded the University of Copenhagen a grant of up to $1.5 million to establish a mass spectrometry facility, advancing protein research significantly. The Global Proteomics Market is expected to gain momentum as activities resume following the disruptions caused by the pandemic.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Proteomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Proteomics Market Segmental Analysis

The global proteomics market is segmented based on the Instrumentation Technology, Reagent, Software &Services, Application, End User and Region. Based on the Instrumentation Technology, the market is segmented into Services, Reagents & Consumables, and Instruments. Based on Reagent, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents, Other Reagents. Based on Software & Services, the market is segmented into Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomics Services, Protein Purification Services, Protein Separation Services, Protein Sequencing Services, Custom Assay Services), Bioinformatics Software & Services (Bioinformatics Services, Bioinformatics Tools, Bioinformatics Databases), Photonic Network, Other Technologies. Based on Application, the market is segmented into Clinical Diagnostics (Cancer, Infectious Diseases, Diabetes, Neurological Disorders, Autoimmune Diseases, Cardiovascular Diseases, Other Clinical Diagnostic Applications), Drug Discovery & Development (Target Discovery, Lead Identification, Preclinical Studies), and Other Applications. Based on End User, the market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Laboratories, and Other End Users. Based on Region, the market is segmneted into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Drivers of the Global Proteomics Market

The growth of the proteomics market is driven by advancements in technologies such as mass spectrometry and complex chromatography, which enhance the precision and speed of protein analysis. These innovations facilitate the identification and quantification of proteins, thereby expanding the application of proteomics in areas such as drug discovery, diagnostics, and clinical settings.

Restraints in the Global Proteomics Market

A challenge associated with proteomic data analysis is its inherent complexity. The process of examining proteomic data can be time-consuming, labor-intensive, and often requires extensive tools, as well as significant time and expertise to operate these tools effectively. This complexity can slow down the research process and potentially diminish the benefits of proteomics for both clinical and research applications.

Market Trends of the Global Proteomics Market

Nano proteomics has emerged from the integration of proteomics technologies with nanotechnology. This field leverages various nano-based approaches, including phosphor proteomics with metal oxide nanoparticles, protein microarrays, and nanostructured surfaces for protein and biomarker detection. Nano proteomics combines traditional proteomics techniques with nanotechnology applications, such as nanoporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures, to enhance analytical capabilities and improve detection and separation of proteins.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Supply chain Analysis
Ecosystem of the Market
Trade Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Proteomics Market by Instrumentation Technology

Market Overview
Spectroscopy
- Mass Spectroscopy
- NMR Spectroscopy
- CD Spectroscopy
Chromatography
- HPLC
- Ion Chromatography
- Affinity Chromatography
- Supercritical Fluid Chromatography
Electrophoresis
- Gel Electrophoresis
- Capillary Electrophoresis
Protein Microarrays
- Biochips
- Lab-on-chips
- Protein chips
- Microarray Instruments
- Integrated systems
- Microarray scanners
- Arrayers
X-Ray Crystallography
Surface Plasmon Resonance
Protein Fractionation
Other Technologies

Proteomics Market by Reagent

Market Overview
Immunoassay Reagents
Spectroscopy Reagents
Chromatography Reagents
Protein Microarray Reagents
X-Ray Crystallography Reagents
Electrophoresis Reagents
Protein Fractionation Reagents
Other Reagents

Proteomics Market by Service & Software

Market Overview
Core Proteomics Services
- Protein Identification Services
- Protein Characterization Services
- Quantitative Proteomics Services
- Protein Purification Services
- Protein Separation Services
- Protein Sequencing Services
- Custom Assay Services
Bioinformatics Software & Services
- Bioinformatics Services
- Bioinformatics Tools
- Bioinformatics Databases
Photonic Network
Other Technologies

Proteomics Market by Application

Market Overview
Clinical Diagnostics
- Cancer
- Infectious Diseases
- Diabetes
- Neurological Disorders
- Autoimmune Diseases
- Cardiovascular Diseases
- Other Clinical Diagnostic Applications
Drug Discovery & Development
- Target Discovery
- Lead Identification
- Preclinical Studies
Other Applications

Proteomics Market by End-User

Market Overview
Hospitals
Clinical Laboratories
Pharmaceutical & Biotechnology Companies
Academic Research Laboratories
Other End Users

Proteomics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN Bioinformatics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Proteomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sengenics (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomax Informatics AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MS Bioworks LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi NextCODE (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fios Genomics Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biognosys AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioproximity (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MRM Proteomics Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments